Department of Medicine
Naples, 80131, Italy
NCT Number: NCT00513201
OBJECTIVE: To compare lispro insulin and regular insulin in the glycemic control of patients with liver cirrhosis and type 2 diabetes subjects. METHODS: 108 patients with liver cirrhosis and type 2 diabetes were randomly treated with regular insulin or lispro. After 122 weeks a cross-over was carried out and patients followed-up for 122 weeks. Then, all patients received a standard breakfast of 145 kcal following 12 U.I. of regular insulin or lispro, and C-peptide and insulin serum levels were determined over 300 minutes.
Looking for future studies?
Notify Me48 year–67 year
All sexes
Interventional
Phase 4
Naples, 80131, Italy
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
University of Campania Luigi Vanvitelli
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05769868
Cirrhosis, Diabetes Mellitus
Barcelona, Spain
View Trial DetailsNCT07728162
Diabetes Mellitus, Disease Attributes
Bolu, Turkey (Türkiye)
View Trial DetailsNCT03771417
Aging, Atrophy
Baton Rouge, Louisiana, United States
View Trial DetailsNCT01073566
Autoimmune Diseases, Diabetes Mellitus
San Francisco, California, United States
View Trial Details